Article
Refine
Document Type
- Article (3) (remove)
Language
- English (3)
Has Fulltext
- yes (3)
Is part of the Bibliography
- no (3)
Keywords
- - (2)
- ATP synthesis (1)
- Immune system (1)
- P188 (1)
- PEG (1)
- Postoperative immune suppression (1)
- Sepsis (1)
- Trauma (1)
- calcium retention capacity (1)
- cardiac (1)
- cardiac arrest (1)
- colon cancer (1)
- copolymer (1)
- gut microbiome (1)
- left-sided colon cancer (1)
- microbiome (1)
- mitochondria (1)
- myocardial infarction (1)
- oxygen consumption (1)
- right-sided colon cancer (1)
- tumor microbiome (1)
Institute
- Klinik und Poliklinik für Chirurgie (3) (remove)
Publisher
- MDPI (2)
- S. Karger AG (1)
In the current era of precision oncology, it is widely acknowledged that CRC is a heterogeneous disease entity. Tumor location (right- or left-sided colon cancer or rectal cancer) is a crucial factor in determining disease progression as well as prognosis and influences disease management. In the last decade, numerous works have reported that the microbiome is an important element of CRC carcinogenesis, progression and therapy response. Owing to the heterogeneous nature of microbiomes, the findings of these studies were inconsistent. The majority of the studies combined colon cancer (CC) and rectal cancer (RC) samples as CRC for analysis. Furthermore, the small intestine, as the major site for immune surveillance in the gut, is understudied compared to the colon. Thus, the CRC heterogeneity puzzle is far from being solved, and more research is necessary for prospective trials that separately investigate CC and RC. Our prospective study aimed to map the colon cancer landscape using 16S rRNA amplicon sequencing in biopsy samples from the terminal ileum, healthy colon tissue, healthy rectal tissue and tumor tissue as well as in preoperative and postoperative stool samples of 41 patients. While fecal samples provide a good approximation of the average gut microbiome composition, mucosal biopsies allow for detecting subtle variations in local microbial communities. In particular, the small bowel microbiome has remained poorly characterized, mainly because of sampling difficulties. Our analysis revealed the following: (i) right- and left-sided colon cancers harbor distinct and diverse microbiomes, (ii) the tumor microbiome leads to a more consistent cancer-defined microbiome between locations and reveals a tumor microbiome–ileal microbiome association, (iii) the stool only partly reflects the microbiome landscape in patients with CC, and (iv) mechanical bowel preparation and perioperative antibiotics together with surgery result in major changes in the stool microbiome, characterized by a significant increase in the abundance of potentially pathogenic bacteria, such as Enterococcus. Collectively, our results provide new and valuable insights into the complex microbiome landscape in patients with colon cancer.
Myocardial infarction is a leading cause for morbidity and mortality worldwide. The only
viable treatment for the ischemic insult is timely reperfusion, which further exacerbates myocardial
injury. Maintaining mitochondrial function is crucial in preserving cardiomyocyte function in
ischemia reperfusion (IR) injury. Poloxamer (P) 188 has been shown to improve cardiac IR injury
by improving cellular and mitochondrial function. The aim of this study was to show if P188
postconditioning has direct protective effects on mitochondrial function in the heart. Langendorff
prepared rat hearts were subjected to IR injury ex-vivo and reperfused for 10 min with 1 mM P188
vs. vehicle. Cardiac mitochondria were isolated with 1 mM P188 vs. 1 mM polyethylene glycol
(PEG) vs. vehicle by differential centrifugation. Mitochondrial function was assessed by adenosine
triphosphate synthesis, oxygen consumption, and calcium retention capacity. Mitochondrial function
decreased significantly after ischemia and showed mild improvement with reperfusion. P188 did
not improve mitochondrial function in the ex-vivo heart, and neither further P188 nor PEG induced
direct mitochondrial protection after IR injury in this model.
Background: In postoperative sepsis, mortality is increased due to the surgically induced immune dysfunction. Further causes of this traumatic effect on the immune system include burn injuries and polytrauma, as well as endogenous traumata like stroke. Several animal models have been defined to analyse the characteristics of trauma-induced immune suppression. This article will correlate our results from animal studies and clinical observations with the recent literature on postoperative immune suppression. Methods: The previously described model of surgically induced immune dysfunction (SID) was performed in mice by laparotomy and manipulation of the small intestine in the antegrade direction. Blood samples were collected 6 and 72 h following SID to analyse the white blood cell count and corticosterone levels. To assess the postoperative immune status in humans, we analysed expression of HLA-DR on monocytes of 118 patients by flow cytometry prior to and 24, 48 and 72 h after surgery. Results: The postoperative immune suppression in our SID model is characterised by lymphocytopenia and significantly increased corticosterone levels in mice dependent on the degree of surgical trauma. This is comparable to the postoperative situation in humans: major and especially long-lasting surgery results in a significantly reduced expression of HLA-DR on circulating monocytes. Previous studies describe a similar situation following burn injury and endogenous trauma, i.e. stroke. Conclusions: We suggest the completion of our previously published sepsis classification due to the immune status at the onset of sepsis: type A as the spontaneously acquired sepsis and type B as sepsis in trauma-induced pre-existing immune suppression.